Status
Conditions
Treatments
About
The purpose of the current study is to demonstrate non-inferiority of everolimus-eluting bioresorbable vascular scaffold to everolimus-eluting stents in patients with chronic total occlusion regarding the antirestenotic efficacy at 8 to 10-month angiographic follow-up.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Clinical inclusion criteria:
Angiographic inclusion criteria:
Exclusion criteria
Clinical exclusion criteria:
Angiographic exclusion criteria:
Primary purpose
Allocation
Interventional model
Masking
17 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal